1 February 2012
Clearbridge BioLoc was awarded with SPRING Singapore 's Technology Enterprise Commercialisation Scheme (TECS) Proof-of-Value (POV) Grant today.
The TECS is a competitive grant awarded to start-ups posessing strong technology Intellectual Property in addition to a scalable business model.
More information can be found here.
Clearbridge BioLoc is a Singapore-based company founded on innovative technology from a Korean partner with the aim of developing affordable and reliable Point-of-Care Testing (POCT) solutions.
Leveraging on novel yet cost-effective technological solutions, Clearbridge BioLoc’s fully automated analytical system, the AssayQuest®, enables remote and rapid processing of biological samples in small quantities, which would otherwise require complex laboratory testing.
RECENT AWARDS: "Most Disruptive Technology Award", TechVenture 2011